CHMP Grants Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With KALYDECO® (ivacaftor) in People Ages 12 and Older With Cystic Fibrosis With the Most Common Genotypes | Public

CHMP Grants Positive Opinion for KAFTRIO® (ivacaftor/tezacaftor/elexacaftor) in Combination With KALYDECO® (ivacaftor) in People Ages 12 and Older With Cystic Fibrosis With the Most Common Genotypes

News imagehttps://www.businesswire.com/news/home/20200626005211/en/CHMP-Grants-Positive-Opinion-KAFTRIO%C2%AE-ivacaftortezacaftorelexacaftor-Combination/